Assay-specific differences in lipemic interference in native and intralipid-supplemented samples

被引：53

作者：

Bornhorst, JA

Roberts, RF

Roberts, WL

机构：

[1] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT USA

[2] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA

来源：

CLINICAL CHEMISTRY | 2004年 / 50卷 / 11期

关键词：

D O I：

10.1373/clinchem.2004.040154

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：2197 / 2201

页数：5

共 13 条

[1]

[Anonymous], 1983, LAB MED, DOI DOI 10.1093/LABMED/14.6.351

[2] Role of lipid and lipoprotein profiles in risk assessment and therapy [J].

Ballantyne, CM ;

Hoogeveen, RC .

AMERICAN HEART JOURNAL, 2003, 146 (02) :227-233

[3]

Cooper G R, 1995, J Int Fed Clin Chem, V7, P23

[4] Intralipid 10%:: Physicochemical characterization [J].

Férézou, J ;

Gulik, A ;

Domingo, N ;

Milliat, F ;

Dedieu, JC ;

Dunel-Erb, S ;

Chevalier, C ;

Bach, AC .

NUTRITION, 2001, 17 (11-12) :930-933

[5]

GLICK MR, 1986, CLIN CHEM, V32, P470

[6]

GRAFMEYER D, 1995, EUR J CLIN CHEM CLIN, V33, P31

[7]

Hortin GL, 1997, CLIN CHEM, V43, P408

[8]

KROLL MH, 1994, CLIN CHEM, V40, P1996

[9]

MARCOVINA SM, 1994, CLIN CHEM, V40, P574

[10]

PEARSON JR, 1991, CLIN CHEM, V37, P2014

← 1 2 →